ADMA Biologics

Grifols SA

Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans

Dilution score: 19/100 (LOW), 999.0 months cash

13F fund flow: neutral, 30 institutional managers

William Blair

Duquesne

Brevan Howard

Schonfeld

Capital Research

Balyasny

ExodusPoint

Point72

Renaissance Tech

Franklin Templeton

118 PubMed publications found for ADMA Biologics

Pharmacokinetic Model Based Sensitivity Analysis to Lower Recruitment Burden for Young Children Requiring Intravenous Immunoglobulin G Replacement.

Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study).

Clinical Study on the Combined Use of Tadalafil and Epalrestat in the Treatment of Diabetic Neurovascular Erectile Dysfunction.

Tudor-based proteomic strategy pan-specifically enriches and identifies protein arginine methylation.

Dose-Response Effect of Watermelon Consumption on Ambulatory Blood Pressure in Adults with Elevated Blood Pressure: A Randomized Controlled Pilot Trial.

Short interest: 10.69% of float, squeeze risk: MODERATE

SW convergence: 64/100 (Bullish Convergence), 1 bullish / 0 bearish signals

<article class="bts-verified-summary" data-ticker="ADMA">
<p>ADMA Biologics (ADMA) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>ADMA has 3 Form 4 insider filings recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0001368514 (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22ADMA%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>

SEC EDGAR — 0001368514

ADMA Biologics (ADMA) — BioTechSigns Verified Summary

ADMA Biologics (ADMA) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

ADMA has 3 Form 4 insider filings recorded at the SEC in the past 30 days[1].

Sources:
[1] SEC EDGAR, 0001368514. Source last updated 2026-04-11, retrieved 2026-04-11.
    https://efts.sec.gov/LATEST/search-index?q=%22ADMA%22&forms=4&dateRange=custom&startdt=2026-03-12&enddt=2026-04-11